Ottawa, July 08, 2025 (GLOBE NEWSWIRE) -- The global CRISPR gene editing market size was valued at USD 4.15 billion in 2024 and is predicted to hit around USD 16.47 billion by 2034, a study published ...
Study identifies a new set of genes and cellular pathway that play a role in the risk of developing Parkinson’s disease Scientists searched the entire human genome using CRISPR interference technology ...
Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...
Crispr Therapeutics ((CRSP)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...
Yale scientists have developed a CRISPR technology that can assess genetic interactions on a host of immunological responses to multiple diseases, including cancer. Now, however, Yale scientists have ...
A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like Sickle Cell, while also proving that chemical tags on DNA – often thought to be ...
Crispr Therapeutics ((CRSP)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback